NCT02332980 · OUTCOME

Change in Markers of Immune Modulation

Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas · Source last updated 2026-06-24

This outcome was registered, but no numerical results were posted in the captured record.

Measure: Not reported
Unit: Not reported
Interval / dispersion: Not reported
Time frame: Baseline to up to 1 year

What was measured

Summarized descriptively by median, minimum, maximum, and interquartile range (continuous factors) or frequency distribution (categorical factors) at each time point. Patterns over time summarized by absolute difference or relative change. Changes across time will be assessed using paired analyses, including Wilcoxon signed rank tests for continuous measures and McNemar's tests for categorical measures. Overall response and complete response will be correlated with continuous factors using Wilcoxon rank sum tests. Jitplots will be used to visually examine differences between groups for continuous factors. Overall response and complete response will be correlated with categorical factors using Fisher's exact tests.

Groups in this outcome

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields

denom Units Selected: Participants
description: Summarized descriptively by median, minimum, maximum, and interquartile range (continuous factors) or frequency distribution (categorical factors) at each time point. Patterns over time summarized by absolute difference or relative change. Changes across time will be assessed using paired analyses, including Wilcoxon signed rank tests for continuous measures and McNemar's tests for categorical measures. Overall response and complete response will be correlated with continuous factors using Wilcoxon rank sum tests. Jitplots will be used to visually examine differences between groups for continuous factors. Overall response and complete response will be correlated with categorical factors using Fisher's exact tests.
reporting Status: NOT_POSTED
time Frame: Baseline to up to 1 year
title: Change in Markers of Immune Modulation
type: OTHER_PRE_SPECIFIED

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice